Influence of development and joint pathology on stromelysin enzyme activity in equine synovial fluid.

This research investigates how stromelysin enzyme activity in horse synovial fluid varies with developmental stages and common joint diseases such as osteochondrosis and osteoarthritis. It indicates a higher stromelysin activity in younger horses and those with osteoarthritis, and suggests this enzyme could play a significant role in joint health and disease.

Methods Used in the Research

• The activity of the stromelysin enzyme, also known as MMP-3, was measured in the synovial fluid (the lubricating fluid in joints) of horses at different stages of development, and those suffering from common joint disorders.
• This was done using a fluorogenic enzyme activity assay, a method which uses a fluorescence response to measure enzyme activity.
• Stromelysin activity was compared in fetal, juvenile, and adult horses, and those with osteochondrosis (OC, a developmental disorder affecting the joints) or osteoarthritis (OA, a degenerative joint disease).
• Furthermore, the researchers compared MMP-3 activity to general MMP (matrix metalloproteinase) activity in the same synovial fluid samples, to assess if there was a relationship between the two.

Main Findings of the Research

• The research found that active stromelysin levels were much higher in the synovial fluid of fetal horses compared to juvenile and adult horses.
• There was also a slightly higher stromelysin activity in juvenile horses compared to adults.
• In horses with OC, stromelysin activity was found to be similar to that in healthy, age-matched control horses, suggesting this enzyme’s activity does not contribute significantly to this specific disorder.
• However, stromelysin activity was significantly higher (around four times) in horses with OA compared to normal joints, indicating a potential involvement of this enzyme in the progression of osteoarthritis.

Conclusions from the Research

• The researchers hypothesized that the higher activity of the stromelysin enzyme in younger horses likely corresponds to increased metabolic activity during periods of rapid growth and differentiation.
• The elevated stromelysin levels found in OA-affected joints could be linked to the pathological degradation of the joint matrix associated with this disease.
• The MMP-3/general MMP activity ratio remained stable with age in healthy joints, but was more than doubled in OA joints, suggesting an upregulation of MMP-3 expression or activation in osteoarthritis pathology.